Study Initiation Meeting

Similar documents
Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

BIMO SITE AUDIT CHECKLIST

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.

WIRBinar. How to Survive an FDA Inspection. Upcoming Trainings: Contact Us: (360)

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Clinical Study Risk Assessment

Standard Operating Procedures

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators

EMA Inspection Site perspective

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

20 STEPS FROM STUDY IDEA INCEPTION TO PUBLISHING RESEARCH/ Evidence-Based Practice

STANDARD OPERATING PROCEDURE SOP 325

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

Document Title: Informed Consent for Research Studies

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Good Clinical Practice: A Ground Level View

SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY

Unofficial copy not valid

VCU Clinical Research Quality Assurance Assessment

Request for Information (RFI): Reducing Investigator s Administrative Workload for Federally Funded Research

Document Title: Study Data SOP (CRFs and Source Data)

Clinical Trial Readiness Checklist October 2014

FDA Inspection Readiness

Joint R&D Support Office SOP S-2011 UHL

Ask the Experts Panel

Record or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;

SOP WP6-QUAL-04, Version 1.0, 23 February 2014 Page 1 of 8. SOP Title: Laboratory (GCLP) supervision visits

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

USING SMART IRB AND SINGLE IRB REVIEW

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees

Investigator Training Program March 9, The Mechanics of Performing a Clinical Trial. Michelle Cavallerano, CCRP Mary Lou Watson, BA, RRT, CCRP

The GCP Perspective on Study Monitoring

Site Closedown Checklist for UoL Sponsored CTIMP Studies

Clinical Research Coordinator - Researcher Startup Tool 1 of 7

Good Documentation Practices. Human Subject Research. for

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

Financial Conflict of Interest Management Plan Guidance (Adopted by the Investigator Financial Disclosure Committee 14 Feb 2014)

IACUC Policy 09: Researcher Non-Compliance

Clinical Research Coordinator - Researcher Startup Tool 1 of 7

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

QUALITY ASSURANCE PROGRAM

UConn Health Office of Clinical & Translational Research Standard Operating Procedures

Comprehensive Protocol Feasibility Questionnaire

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies

PLATELET-ORIENTED INHIBITION ISCHEMIC STROKE (POINT) MONITORING PLAN IN NEW TIA AND MINOR. Version 2.0 Updated 11 May 2017

Storage and Use of Newborn Screening Blood Spot Cards New Requirements June 1, 2012

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

Investigator Site File Standard Operating Procedure (SOP)

Request to Use an External IRB as an IRB of Record

SAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California. STANDARD OPERATING PROCEDURES Institutional Review Board

PI Department. 12. Project Period Start 07/01/15 End 06/30/ Budget Period Start 07/01/15 End 06/30/ Award Type. 17.

MUSC Center for Global Health Request for Applications (RFA) for Faculty Pilot Project Grants

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

(Insert additional Principal Investigators in the Comments section.) Co-Investigator Data Investigators Employee # School

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

Title: OFFICE OF SPONSORED PROGRAMS/IRB/ORIP COORDINATION

DO I NEED TO SUBMIT FOR THIS?... & OTHER FREQUENTLY ASKED QUESTIONS. March 2015 IRB Forum

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

Quality and Safety Committee Terms of Reference

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:

Research Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES

Review & Negotiation Process for Sponsor & Investigator Initiated Clinical Trial Agreements

Pacific Northwest Transportation Consortium Funded Projects PI Information Meeting

QUALITY TIPS FOR CLINICAL SITES. Athena Thomas-Visel. Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES

REQUEST TO ACCESS EXISTING MEDICAL RECORDS, CHARTS OR DATABASES FOR RESEARCH

Checklist prior to recruiting first patient

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.

Overview ICH GCP E6(R2) Integrated Addendum

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH

Sponsored Program Administration

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting

Study Monitoring Plan Template

Research Administration Services Roles & Responsibilities For Grants and Contracts (Excludes Clinical Trials) Version 3.1

EMA & FDA Inspections: Site perspective. Shandukani Research Centre

ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM

2015 TEXAS MEDICAL RESEARCH COLLABORATIVE (TEXASMRC): PROPOSAL SUBMISSION GUIDELINES

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Clinical Trial Quality Assurance Common Findings

M. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager

1. INTRODUCTION 2. SCOPE 3. PROCESS

Sponsored Programs Roles & Responsibilities

FDA Medical Device Regulations vs. ISO 14155

Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Medicare Coverage Analysis. BWH qualifying study training and discussion

College of Veterinary Medicine Frequently Asked Questions

managing or activities.

Mastering Clinical Research April 19, :30 am

Policy on Minors in Laboratories

STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.

Subrecipient Monitoring Procedures

Transcription:

Puerto Rico Clinical and Translational Research Consortium Study Initiation Meeting I. Procedure Title: Study Initiation Meeting II. Overview/Procedure Description: 1. The Clinical Research Resources and Facilities Core (CRF) Coordinator is responsible for conducting the study initiation meeting for each protocol approved at the Puerto Rico Clinical and Translational Research Consortium (PRCTRC) 2. If requesting include only services from the Technologies and Resources for Core Laboratories (TRCL): The TRCL Laboratory Manager is responsible for conducting the study initiation meeting for each protocol approved at the PRCTRC. III. Purposes: 1. For the Investigator a. To understand the specific activities required in order to begin receiving services from the PRCTRC, b. To meet the PRCTRC personnel who will provide support for the study. 2. For the PRCTRC Staff a. To meet the Principal Investigator (PI) and the staff who will be conducting the study; b. To understand the study s objectives and activities. IV. Area(s) of Responsibility: Clinical Research Resources and Facilities Core (CRF), Technologies and Resources for Core Laboratories (TRCL), Administrative Core (AC), Principal Investigator (PI), Co-Investigators (CO-PIs), Study Coordinator (SC), Regulatory Knowledge and Support Core (RKS) V. Procedure Details: Responsibilities Before the Study Initiation Meeting: a. After receiving the PRCTRC Approval Letter, the Principal Investigator (PI) is responsible for contacting the CRF Coordinator in order to make arrangements for the study initiation meeting; b. After receiving the confirmation email from the CRF Coordinator for the study initiation meeting, the PI is responsible of making arrangements for her/his staff to attend the initiation meeting; 1 R KS

c. If pertinent, the PI will prepare documentation related with the study (hard copy and/or Power Point Presentation) to present his/her needs to the PRCTRC staff during the initiation meeting. a. Once the Principal Investigator has agreed on a date, the CRF Core Coordinator is responsible for sending an email to the PI with the date, time, and location of the meeting, including the agenda (see Attachment A); b. The CRF Core Coordinator is responsible for sending an Invitational email for the meeting to the PRCTRC key personnel, including the agenda (see Attachment A). a. The Head Nurse is responsible for meeting with the nursing staff and reviewing the Application Form in order to: Discuss and evaluate the Nursing Services requested by the PI. Complete an assessment of the nursing services requested by the PI; Clarify any doubt or question related to the protocol nursing procedures (ex. Vital signs, phlebotomy, anthropometric measures, etc.) 4. Technologies and Resources for Core Laboratories (TRCL): a. The Laboratory Manager is responsible for meeting with the Laboratory staff and reviewing Application Form in order to: Complete an assessment of the laboratory services requested by the PI; Complete an assessment of the availability of the equipment requested by the PI (if applicable); Dedicate attention to areas of discussion or questions; Review the study s Laboratory Manual. a. The PRCTRC Administrator is responsible for meeting with the Administrative staff and reviewing the Application Form in order to: Complete an assessment of the services requested by the PI; Prepare an Administrative fee draft for the study. a. The Research Subject Advocate is responsible for: Create a study file with regulatory documents (IRB, IBC, IACUC); Review the Delegation of Responsibilities and Signature Log to ensure study personnel s responsibilities are well defined; Review that all personnel listed in the Delegation of Responsibilities and Signature Log submit updated training certifications and other requirements. Responsibilities During the Study Initiation Meeting: a. The PI will: Present a summary of the protocol including: background and purpose of the study, the number of participants to be recruited, the inclusion and exclusion criteria, recruitment period, study treatment procedures, special tests and 2 R KS

procedures, study drug management (if applicable) and specimen management (if applicable); Confirm that all materials and/or equipment necessary to conduct protocol related activities have been received at the PRCTRC. These may include, but are not limited to: Procedure Manual (if any), Test Articles (if appropriate to study), laboratory kits, laboratory manual and supplies (if appropriate to study), and any other materials and/or equipment as appropriate to study. Answer questions that result from the protocol presentation; a. The CRF Core Coordinator will: Conduct the meeting; Have all participants sign an attendance list; Take notes of the agreements; Close the meeting. a. The Head Nurse will: Review the Nursing Services Sheet; Clarify any doubt or question related to the Nursing Services required; Record items that are relevant to nursing services and facilities; Go over the CRF SOPs. 3. Technologies and Resources for Core Laboratories (TRCL): a. The Laboratory Manager will: Clarify any doubt regarding lab procedures and the use of equipment requested (if applicable); Dedicate attention to areas of discussion or questions; Record items that are relevant to lab procedures and facilities; Go over the TRCL SOPs. a. The PRCTRC Administrator will: Present the Administrative fee draft; Answer any question about the Administrative fee draft; Request contact information for the invoice procedure; Go over the AC SOPs. a. The Research Subject Advocate will: Request documentation, if needed, for compliance with regulatory requirements Match the study staff with the Delegation of Responsibilities and Signature Log ; Go over the RKS SOPs. 3 R KS

Responsibilities After the Study Initiation Meeting: a. The PI will: Keep ongoing communication with PRCTRC personnel; Inform any changes to protocol requirements. a. The CRF Coordinator will: Prepare a meeting report and send it to the PI and other cores; File the original attendance list in the study record; Provide a copy of the attendance list for the RKS Core file. a. The Head Nurse will: Follow up any issues identified for further clarification; Maintain frequent communication with the PI; Frequently review the protocol procedures and implement any change approved by the IRB. 4. Technologies and Resources for Core Laboratories (TRCL): a. The Laboratory Manager will: Keep ongoing communication with the PI; Take care of any question, situation or change related with TRCL, which may arise during the period that the protocol is active. a. The Administrator will: Keep ongoing communication with the PI; Take care of any question, situation or change related with AC, which may arise during the period that the protocol is active. a. The Research Subject Advocate will: Reconcile any document irregularities; File the copy of the attendance record in the study file; Keep ongoing communication with the PI for regulatory updates and changes to protocol requirements. 4 R KS

Attachment A Study Initiation Meeting AGENDA 5 minutes Welcome and introductions CRF Coordinator 15 minutes Protocol review Principal Investigator 10 minutes Review of the CRF procedures Head Nurse 10 minutes Review of the TRCL procedures Lab Manager 10 minutes Review of the Administrative fee Administrator 10 minutes Review of updated regulatory documents on Investigator file RSA 5 minutes Summary/close the meeting CRF Coordinator 5 R KS